《新股消息》天任集團(01429.HK)今日起招股 入場費3,555.5元
本港模板工程分包商天任集團(01429.HK)公布招股詳情,計劃發售4億股新股,當中10%為本港公開發售,招股價介乎0.35元至0.44元。每手8,000股,入場費為3,555.47元,由今日(15日)至本周五(18日)公開招股,預計於9月29日上市。同人融資為獨家保薦人。
以發售價中位數0.395元計,公司預計所得款項淨額將約為9,800萬元,當中約60.8%用於支付若干前期成本及開支、擬投標的未來項目而用於系統模板的鋁模板的購置成本;21.6%用於增加金屬通架設備及相關零件庫存;9%用作進一步加強人力資源;以及餘下8.6%用作集團一般營運資金用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.